Eye cancer: the promise of immunotherapy
Tebentafusp, a new immunotherapy treatment, would improve the survival of patients with uveal melanoma, the most common form of eye ...
Read moreTebentafusp, a new immunotherapy treatment, would improve the survival of patients with uveal melanoma, the most common form of eye ...
Read more